Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1500585
European Journal of Endocrinology, Vol 150, Issue 4, 585-590
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pascual-Le Tallec, L
Right arrow Articles by Lombes, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pascual-Le Tallec, L
Right arrow Articles by Lombes, M
Articles

Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities

L Pascual-Le Tallec, C Demange, and M Lombes

INSERM U478, IFR Claude Bernard, Faculte de Medecine Xavier Bichat, 75870 Paris cedex 18, France.

OBJECTIVE: Aldosterone binds the mineralocorticoid receptor (MR) and is involved in the regulation of ionic transport, mainly sodium retention. MR is encoded by one single gene transcribed into various messengers that are thought to be translated into a unique 107 kDa protein. The aim of this study was to identify and characterize translation initiation variants of the human MR protein. METHODS: For this purpose we analyzed the extreme N-terminal fragment of various MR species, and confronted the predicted pattern of expression with in vitro translation results. Transactivation functions of the identified MR forms obtained by targeted mutagenesis were evaluated by transient transfection assays with different promoter reporter genes. RESULTS: Two major forms of human MR (hMR), named MRA and MRB, generated by alternative initiation of translation from start methionine 1 and 15 respectively, were predicted. Their expected expressions were confirmed by in vitro transcription/translation studies. Interestingly, each form of MR displayed reduced transactivation capacities with wild type (WT)=A+B>MRA>MRB suggesting that the extreme N-terminal fragment of MR has an effect on the transcriptional properties of the receptor. CONCLUSIONS: Altogether these data indicate that MR is expressed, through alternative translation initiation, as distinct protein variants which possess different functional properties. These MR forms could tightly dictate the modulation of aldosterone responsiveness in various tissues or in pathophysiological situations.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
C. E. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, J. Estess, M. P. Warden, M. T. Gomez-Sanchez, and E. P. Gomez-Sanchez
Development of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor
Endocrinology, March 1, 2006; 147(3): 1343 - 1348.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. Pascual-Le Tallec and M. Lombes
The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action
Mol. Endocrinol., September 1, 2005; 19(9): 2211 - 2221.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.